Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010
Highlights ► Health problems detected were comparable with baseline data of the districts. ► Documented safety profile consistent with monovalent PS conjugate vaccine (ex: Hib). ► No outstanding safety issue with MenAfriVac ™. ► Hypersensitivity reactions require further assessment to rule out anaph...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2012-05, Vol.30, p.B46-B51 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | B51 |
|---|---|
| container_issue | |
| container_start_page | B46 |
| container_title | Vaccine |
| container_volume | 30 |
| creator | Ouandaogo, Claude-Roger Yaméogo, Téné M Diomandé, Fabien V.K Sawadogo, Charles Ouédraogo, Bassirou Ouédraogo-Traoré, Rasmata Pezzoli, Lorenzo Djingarey, Mamoudou H Mbakuliyemo, Nehémie Zuber, Patrick L.F |
| description | Highlights ► Health problems detected were comparable with baseline data of the districts. ► Documented safety profile consistent with monovalent PS conjugate vaccine (ex: Hib). ► No outstanding safety issue with MenAfriVac ™. ► Hypersensitivity reactions require further assessment to rule out anaphylactic reactions. |
| doi_str_mv | 10.1016/j.vaccine.2011.12.112 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1516742259</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X11020731</els_id><sourcerecordid>1016674350</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-aa8bd51e0239da7f5247e1210081fbd3f6d7e93b9b3692734a9b8ec101a906453</originalsourceid><addsrcrecordid>eNqFksFu1DAQhiMEotvCIwA-cmgWjx3HyYVqqSggVeJQKnGzHGeycprYi50sKo_C0-JtFg5cerI0_v7fnvkny14BXQOF8l2_3mtjrMM1owBrYGsA9iRbQSV5zgRUT7MVZWWRF0C_n2SnMfaUUsGhfp6dMMY4FVWxyn5v2j2GiAT36KZIOj8M_qd1W2LHcXb2l56sd6Sdw6E26hjJ8u5SN3rcabt1keiJdDbEiVg3Bd_O5uHed0STEV0Se-ON0QPZEONdP2_1hEcrTBryYQ53yZVc6ejPSeqJvsiedXqI-PJ4nmW3Vx-_XX7Or79--nK5uc5NIeWUa101rQCkjNetlp1ghURgQGkFXdPyrmwl1rypG17WTPJC102FJg1R17QsBD_L3i6-u-B_zBgnNdpocBi0Qz9HBQJKWTAm6sfRlExiuaAJFQtqgo8xYKd2wY463CfogVO9OravDgkqYColmHSvj0_MzYjtP9XfyBLwZgE67ZXeBhvV7U1yEJSCrLiQibhYCExT21sMKhqLzmBrA5pJtd4--on3_zmYwTqb4rvDe4y9n4NLkShQkSmqbg6LdtgzAMqo5MD_AAtczo4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1016674350</pqid></control><display><type>article</type><title>Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Ouandaogo, Claude-Roger ; Yaméogo, Téné M ; Diomandé, Fabien V.K ; Sawadogo, Charles ; Ouédraogo, Bassirou ; Ouédraogo-Traoré, Rasmata ; Pezzoli, Lorenzo ; Djingarey, Mamoudou H ; Mbakuliyemo, Nehémie ; Zuber, Patrick L.F</creator><creatorcontrib>Ouandaogo, Claude-Roger ; Yaméogo, Téné M ; Diomandé, Fabien V.K ; Sawadogo, Charles ; Ouédraogo, Bassirou ; Ouédraogo-Traoré, Rasmata ; Pezzoli, Lorenzo ; Djingarey, Mamoudou H ; Mbakuliyemo, Nehémie ; Zuber, Patrick L.F</creatorcontrib><description>Highlights ► Health problems detected were comparable with baseline data of the districts. ► Documented safety profile consistent with monovalent PS conjugate vaccine (ex: Hib). ► No outstanding safety issue with MenAfriVac ™. ► Hypersensitivity reactions require further assessment to rule out anaphylactic reactions.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2011.12.112</identifier><identifier>PMID: 22230584</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Adverse Drug Reaction Reporting Systems - organization & administration ; AEFI ; Africa ; Allergy and Immunology ; anaphylaxis ; Burkina Faso - epidemiology ; Child ; Child, Preschool ; Drug-Related Side Effects and Adverse Reactions - epidemiology ; elderly ; Female ; fever ; headache ; Humans ; Incidence ; Infant ; Male ; Mass Vaccination - adverse effects ; MenAfriVac ; meningitis ; Meningococcal Infections - epidemiology ; Meningococcal Infections - prevention & control ; Meningococcal Vaccines - administration & dosage ; Meningococcal Vaccines - adverse effects ; Meningococcal Vaccines - immunology ; Monitoring ; Neisseria meningitidis ; people ; Pharmacovigilance ; Safety ; seizures ; urticaria ; vaccination ; Vaccine ; vaccines ; vomiting ; Young Adult</subject><ispartof>Vaccine, 2012-05, Vol.30, p.B46-B51</ispartof><rights>2011</rights><rights>Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-aa8bd51e0239da7f5247e1210081fbd3f6d7e93b9b3692734a9b8ec101a906453</citedby><cites>FETCH-LOGICAL-c477t-aa8bd51e0239da7f5247e1210081fbd3f6d7e93b9b3692734a9b8ec101a906453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.vaccine.2011.12.112$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974,64364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22230584$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ouandaogo, Claude-Roger</creatorcontrib><creatorcontrib>Yaméogo, Téné M</creatorcontrib><creatorcontrib>Diomandé, Fabien V.K</creatorcontrib><creatorcontrib>Sawadogo, Charles</creatorcontrib><creatorcontrib>Ouédraogo, Bassirou</creatorcontrib><creatorcontrib>Ouédraogo-Traoré, Rasmata</creatorcontrib><creatorcontrib>Pezzoli, Lorenzo</creatorcontrib><creatorcontrib>Djingarey, Mamoudou H</creatorcontrib><creatorcontrib>Mbakuliyemo, Nehémie</creatorcontrib><creatorcontrib>Zuber, Patrick L.F</creatorcontrib><title>Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Highlights ► Health problems detected were comparable with baseline data of the districts. ► Documented safety profile consistent with monovalent PS conjugate vaccine (ex: Hib). ► No outstanding safety issue with MenAfriVac ™. ► Hypersensitivity reactions require further assessment to rule out anaphylactic reactions.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Adverse Drug Reaction Reporting Systems - organization & administration</subject><subject>AEFI</subject><subject>Africa</subject><subject>Allergy and Immunology</subject><subject>anaphylaxis</subject><subject>Burkina Faso - epidemiology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Drug-Related Side Effects and Adverse Reactions - epidemiology</subject><subject>elderly</subject><subject>Female</subject><subject>fever</subject><subject>headache</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Male</subject><subject>Mass Vaccination - adverse effects</subject><subject>MenAfriVac</subject><subject>meningitis</subject><subject>Meningococcal Infections - epidemiology</subject><subject>Meningococcal Infections - prevention & control</subject><subject>Meningococcal Vaccines - administration & dosage</subject><subject>Meningococcal Vaccines - adverse effects</subject><subject>Meningococcal Vaccines - immunology</subject><subject>Monitoring</subject><subject>Neisseria meningitidis</subject><subject>people</subject><subject>Pharmacovigilance</subject><subject>Safety</subject><subject>seizures</subject><subject>urticaria</subject><subject>vaccination</subject><subject>Vaccine</subject><subject>vaccines</subject><subject>vomiting</subject><subject>Young Adult</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFksFu1DAQhiMEotvCIwA-cmgWjx3HyYVqqSggVeJQKnGzHGeycprYi50sKo_C0-JtFg5cerI0_v7fnvkny14BXQOF8l2_3mtjrMM1owBrYGsA9iRbQSV5zgRUT7MVZWWRF0C_n2SnMfaUUsGhfp6dMMY4FVWxyn5v2j2GiAT36KZIOj8M_qd1W2LHcXb2l56sd6Sdw6E26hjJ8u5SN3rcabt1keiJdDbEiVg3Bd_O5uHed0STEV0Se-ON0QPZEONdP2_1hEcrTBryYQ53yZVc6ejPSeqJvsiedXqI-PJ4nmW3Vx-_XX7Or79--nK5uc5NIeWUa101rQCkjNetlp1ghURgQGkFXdPyrmwl1rypG17WTPJC102FJg1R17QsBD_L3i6-u-B_zBgnNdpocBi0Qz9HBQJKWTAm6sfRlExiuaAJFQtqgo8xYKd2wY463CfogVO9OravDgkqYColmHSvj0_MzYjtP9XfyBLwZgE67ZXeBhvV7U1yEJSCrLiQibhYCExT21sMKhqLzmBrA5pJtd4--on3_zmYwTqb4rvDe4y9n4NLkShQkSmqbg6LdtgzAMqo5MD_AAtczo4</recordid><startdate>20120530</startdate><enddate>20120530</enddate><creator>Ouandaogo, Claude-Roger</creator><creator>Yaméogo, Téné M</creator><creator>Diomandé, Fabien V.K</creator><creator>Sawadogo, Charles</creator><creator>Ouédraogo, Bassirou</creator><creator>Ouédraogo-Traoré, Rasmata</creator><creator>Pezzoli, Lorenzo</creator><creator>Djingarey, Mamoudou H</creator><creator>Mbakuliyemo, Nehémie</creator><creator>Zuber, Patrick L.F</creator><general>Elsevier Ltd</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7T5</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>20120530</creationdate><title>Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010</title><author>Ouandaogo, Claude-Roger ; Yaméogo, Téné M ; Diomandé, Fabien V.K ; Sawadogo, Charles ; Ouédraogo, Bassirou ; Ouédraogo-Traoré, Rasmata ; Pezzoli, Lorenzo ; Djingarey, Mamoudou H ; Mbakuliyemo, Nehémie ; Zuber, Patrick L.F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-aa8bd51e0239da7f5247e1210081fbd3f6d7e93b9b3692734a9b8ec101a906453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Adverse Drug Reaction Reporting Systems - organization & administration</topic><topic>AEFI</topic><topic>Africa</topic><topic>Allergy and Immunology</topic><topic>anaphylaxis</topic><topic>Burkina Faso - epidemiology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Drug-Related Side Effects and Adverse Reactions - epidemiology</topic><topic>elderly</topic><topic>Female</topic><topic>fever</topic><topic>headache</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Male</topic><topic>Mass Vaccination - adverse effects</topic><topic>MenAfriVac</topic><topic>meningitis</topic><topic>Meningococcal Infections - epidemiology</topic><topic>Meningococcal Infections - prevention & control</topic><topic>Meningococcal Vaccines - administration & dosage</topic><topic>Meningococcal Vaccines - adverse effects</topic><topic>Meningococcal Vaccines - immunology</topic><topic>Monitoring</topic><topic>Neisseria meningitidis</topic><topic>people</topic><topic>Pharmacovigilance</topic><topic>Safety</topic><topic>seizures</topic><topic>urticaria</topic><topic>vaccination</topic><topic>Vaccine</topic><topic>vaccines</topic><topic>vomiting</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ouandaogo, Claude-Roger</creatorcontrib><creatorcontrib>Yaméogo, Téné M</creatorcontrib><creatorcontrib>Diomandé, Fabien V.K</creatorcontrib><creatorcontrib>Sawadogo, Charles</creatorcontrib><creatorcontrib>Ouédraogo, Bassirou</creatorcontrib><creatorcontrib>Ouédraogo-Traoré, Rasmata</creatorcontrib><creatorcontrib>Pezzoli, Lorenzo</creatorcontrib><creatorcontrib>Djingarey, Mamoudou H</creatorcontrib><creatorcontrib>Mbakuliyemo, Nehémie</creatorcontrib><creatorcontrib>Zuber, Patrick L.F</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ouandaogo, Claude-Roger</au><au>Yaméogo, Téné M</au><au>Diomandé, Fabien V.K</au><au>Sawadogo, Charles</au><au>Ouédraogo, Bassirou</au><au>Ouédraogo-Traoré, Rasmata</au><au>Pezzoli, Lorenzo</au><au>Djingarey, Mamoudou H</au><au>Mbakuliyemo, Nehémie</au><au>Zuber, Patrick L.F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2012-05-30</date><risdate>2012</risdate><volume>30</volume><spage>B46</spage><epage>B51</epage><pages>B46-B51</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Highlights ► Health problems detected were comparable with baseline data of the districts. ► Documented safety profile consistent with monovalent PS conjugate vaccine (ex: Hib). ► No outstanding safety issue with MenAfriVac ™. ► Hypersensitivity reactions require further assessment to rule out anaphylactic reactions.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>22230584</pmid><doi>10.1016/j.vaccine.2011.12.112</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2012-05, Vol.30, p.B46-B51 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1516742259 |
| source | MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
| subjects | Adolescent Adult Adverse Drug Reaction Reporting Systems - organization & administration AEFI Africa Allergy and Immunology anaphylaxis Burkina Faso - epidemiology Child Child, Preschool Drug-Related Side Effects and Adverse Reactions - epidemiology elderly Female fever headache Humans Incidence Infant Male Mass Vaccination - adverse effects MenAfriVac meningitis Meningococcal Infections - epidemiology Meningococcal Infections - prevention & control Meningococcal Vaccines - administration & dosage Meningococcal Vaccines - adverse effects Meningococcal Vaccines - immunology Monitoring Neisseria meningitidis people Pharmacovigilance Safety seizures urticaria vaccination Vaccine vaccines vomiting Young Adult |
| title | Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T07%3A59%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adverse%20events%20following%20immunization%20during%20mass%20vaccination%20campaigns%20at%20first%20introduction%20of%20a%20meningococcal%20A%20conjugate%20vaccine%20in%20Burkina%20Faso,%202010&rft.jtitle=Vaccine&rft.au=Ouandaogo,%20Claude-Roger&rft.date=2012-05-30&rft.volume=30&rft.spage=B46&rft.epage=B51&rft.pages=B46-B51&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2011.12.112&rft_dat=%3Cproquest_cross%3E1016674350%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1016674350&rft_id=info:pmid/22230584&rft_els_id=S0264410X11020731&rfr_iscdi=true |